Lista de obras - Chiara Braconi - Dominio Público Uruguay

Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis.

artículo científico publicado en 2017

Candidate therapeutic agents for hepatocellular cancer can be identified from phenotype-associated gene expression signatures.

artículo científico publicado en 2009

Capecitabine and mitomycin C may be an effective treatment option for third-line chemotherapy in advanced colorectal cancer.

artículo científico publicado en 2006

Carbon dating cancer: defining the chronology of metastatic progression in colorectal cancer

artículo científico publicado en 2017

Characterisation of the immune-related transcriptome in resected biliary tract cancers

artículo científico publicado en 2017

Cholangiocarcinoma 2020: the next horizon in mechanisms and management

artículo científico publicado en 2020

Cholangiocarcinoma: State-of-the-art knowledge and challenges

scientific article published on 01 May 2019

Cholangiocarcinoma: new insights into disease pathogenesis and biology.

artículo científico publicado en 2010

Current and novel therapeutic opportunities for systemic therapy in biliary cancer

artículo científico publicado en 2020

Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial ⬇️

artículo científico publicado en 2016

Efficacy and Cardiotoxic Safety Profile of Raltitrexed in Fluoropyrimidines-Pretreated or High-Risk Cardiac Patients With GI Malignancies: Large Single-Center Experience

scientific article published on 29 September 2018

Emerging molecular targets and therapy for cholangiocarcinoma

artículo científico

Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma ⬇️

artículo científico publicado el 27 de diciembre de 2010

Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study.

artículo científico

Hepatic miR‐29ab1 expression modulates chronic hepatic injury ⬇️

artículo científico publicado el 1 de noviembre de 2012

Hepatitis C Virus Proteins Modulate MicroRNA Expression and Chemosensitivity in Malignant Hepatocytes

artículo científico publicado en 2010

Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients

scientific article published on 27 March 2008

Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth

artículo científico publicado en 2011

Investigating the feasibility of tumour molecular profiling in gastrointestinal malignancies in routine clinical practice

artículo científico publicado en 2018

KIT and PDGFRA mutations and the risk of GI stromal tumor recurrence

artículo científico publicado en 2015

KIT and PDGFRalpha mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based study

scientific article published on 10 January 2008

KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer.

artículo científico publicado en 2018

Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial.

artículo científico publicado en 2018

MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma

artículo científico publicado en 2017

MIR21-induced loss of junctional adhesion molecule A promotes activation of oncogenic pathways, progression and metastasis in colorectal cancer

artículo científico publicado en 2021

MiR-21 up-regulation in ampullary adenocarcinoma and its pre-invasive lesions

artículo científico publicado en 2018

MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma.

artículo científico publicado en 2016

MicroRNA expression profiling: a molecular tool for defining the phenotype of hepatocellular tumors

scientific article published on 01 June 2008

MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer

artículo científico publicado en 2014

MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2) ⬇️

artículo científico publicado el 15 de noviembre de 2010

Modulation of mismatch repair and genomic stability by miR-155

artículo científico publicado en 2010

Molecular perturbations in cholangiocarcinoma: Is it time for precision medicine?

artículo científico publicado en 2019

Molecular targets in Gastrointestinal Stromal Tumors (GIST) therapy.

artículo científico publicado en 2008

Non-Coding RNAs in Primary Liver Cancer

artículo científico

Non-coding RNAs as therapeutic targets in hepatocellular cancer.

artículo científico publicado en 2012

Noncoding RNA in Cholangiocarcinoma

scientific article published on 07 December 2018

Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know?

artículo científico publicado en 2016

Oligometastatic gastric cancer: An emerging clinical entity with distinct therapeutic implications

artículo científico publicado en 2018

Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma.

artículo científico publicado en 2016

Paclitaxel and epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil for patients with stage IIIC breast cancer with ten or more involved axillary lymph nodes

artículo científico publicado en 2006

Pathogenetic Role and Clinical Implications of Regulatory RNAs in Biliary Tract Cancer

artículo científico publicado en 2020

Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.

artículo científico publicado en 2018

Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial.

artículo científico publicado en 2015

Regulation of miR-483-3p by the O-linked N-acetylglucosamine transferase links chemosensitivity to glucose metabolism in liver cancer cells.

artículo científico publicado en 2017

Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.

artículo científico

Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients.

artículo científico publicado en 2016

Sorafenib for the Treatment of Advanced Hepatocellular Cancer - a UK Audit

artículo científico publicado en 2016

Targeting the IL-6 Dependent Phenotype Can Identify Novel Therapies for Cholangiocarcinoma ⬇️

artículo científico publicado el 16 de diciembre de 2010

The role of microRNAs in human liver cancers

artículo científico publicado en 2011

Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis ⬇️

artículo científico publicado en 2014

Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers

artículo científico publicado en 2016

[Paraneoplastic syndromes: a review]

scientific article published on 01 November 2005

miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trial

scientific article published on 05 February 2016

miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis

artículo científico publicado en 2018

miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C Trial

artículo científico publicado en 2019

microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer ⬇️

artículo científico publicado el 30 de mayo de 2011

Lista de obras de Chiara Braconi

Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis.

Candidate therapeutic agents for hepatocellular cancer can be identified from phenotype-associated gene expression signatures.

Capecitabine and mitomycin C may be an effective treatment option for third-line chemotherapy in advanced colorectal cancer.

Carbon dating cancer: defining the chronology of metastatic progression in colorectal cancer

Characterisation of the immune-related transcriptome in resected biliary tract cancers

Cholangiocarcinoma 2020: the next horizon in mechanisms and management

Cholangiocarcinoma: State-of-the-art knowledge and challenges

Cholangiocarcinoma: new insights into disease pathogenesis and biology.

Current and novel therapeutic opportunities for systemic therapy in biliary cancer

Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial ⬇️

Efficacy and Cardiotoxic Safety Profile of Raltitrexed in Fluoropyrimidines-Pretreated or High-Risk Cardiac Patients With GI Malignancies: Large Single-Center Experience

Emerging molecular targets and therapy for cholangiocarcinoma

Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma ⬇️

Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study.

Hepatic miR‐29ab1 expression modulates chronic hepatic injury ⬇️

Hepatitis C Virus Proteins Modulate MicroRNA Expression and Chemosensitivity in Malignant Hepatocytes

Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients

Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth

Investigating the feasibility of tumour molecular profiling in gastrointestinal malignancies in routine clinical practice

KIT and PDGFRA mutations and the risk of GI stromal tumor recurrence

KIT and PDGFRalpha mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based study

KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer.

Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial.

MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma

MIR21-induced loss of junctional adhesion molecule A promotes activation of oncogenic pathways, progression and metastasis in colorectal cancer

MiR-21 up-regulation in ampullary adenocarcinoma and its pre-invasive lesions

MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma.

MicroRNA expression profiling: a molecular tool for defining the phenotype of hepatocellular tumors

MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer

MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2) ⬇️

Modulation of mismatch repair and genomic stability by miR-155

Molecular perturbations in cholangiocarcinoma: Is it time for precision medicine?

Molecular targets in Gastrointestinal Stromal Tumors (GIST) therapy.

Non-Coding RNAs in Primary Liver Cancer

Non-coding RNAs as therapeutic targets in hepatocellular cancer.

Noncoding RNA in Cholangiocarcinoma

Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know?

Oligometastatic gastric cancer: An emerging clinical entity with distinct therapeutic implications

Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma.

Paclitaxel and epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil for patients with stage IIIC breast cancer with ten or more involved axillary lymph nodes

Pathogenetic Role and Clinical Implications of Regulatory RNAs in Biliary Tract Cancer

Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.

Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial.

Regulation of miR-483-3p by the O-linked N-acetylglucosamine transferase links chemosensitivity to glucose metabolism in liver cancer cells.

Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.

Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients.

Sorafenib for the Treatment of Advanced Hepatocellular Cancer - a UK Audit

Targeting the IL-6 Dependent Phenotype Can Identify Novel Therapies for Cholangiocarcinoma ⬇️

The role of microRNAs in human liver cancers

Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis ⬇️

Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers

[Paraneoplastic syndromes: a review]

miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trial

miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis

miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C Trial

microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer ⬇️